Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of whey
2016
Kim, D.J., Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea | Kang, M.J., Chonnam National University, Gwangju, Republic of Korea | Choi, J.A., Konyang University, Daejeon, Republic of Korea | Na, D.S., Lifetree Bitotech Co. Ltd., Gyeonggi, Republic of Korea | Kim, J.B., Lifetree Bitotech Co. Ltd., Gyeonggi, Republic of Korea | Na, C.S., Lifetree Bitotech Co. Ltd., Gyeonggi, Republic of Korea | Park, J.H., Chonnam National University, Gwangju, Republic of Korea
Helicobacter pylori colonizes the gastric mucosa of about half of the world's population, causing chronic gastritis and gastric cancer. An increasing emergence of antibiotic-resistant H. pylori arouses demand on alternative non-antibiotic-based therapies. In this study, we freshly prepared crude N-acetylneuraminic acid obtained from glycomacropeptide (G-NANA) of whey through a neuraminidase-mediated reaction and evaluated its antibacterial ability against H. pylori and H. felis. Overnight cultures of the H. pylori were diluted with fresh media and different concentrations (1-150 mg/mL) of crude G-NANA were added directly to the culture tube. Bacterial growth was evaluated by measuring the optical density of the culture medium and the number of viable bacteria was determined by a direct count of the colony forming units (CFU) on agar plates. For the in vivo study, mice were orally infected with 100 μL (5 x 10∨8 cfu/mL) of H. felis four times at a day's interval, accompanied by a daily administration of crude G-NANA or vehicle. A day after the last infection, the mice were daily administered the crude G-NANA (0, 75, and 300 mg/mL) for 10 days and euthanized. Their stomachs were collected and bacterial colonization was determined by quantitative real-time PCR. Crude G-NANA inhibited H. pylori's growth and reduced the number of viable bacteria in a dose-dependent manner. Furthermore, crude G-NANA inhibited bacterial colonization in the mice. These results showed that crude G-NANA has antibacterial activity against Helicobacter and demonstrated its therapeutic potential for the prevention of chronic gastritis and gastric carcinogenesis induced by Helicobacter infection in humans.
显示更多 [+] 显示较少 [-]